129 related articles for article (PubMed ID: 17681974)
1. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.
Du QS; Wei YT; Pang ZW; Chou KC; Huang RB
Protein Eng Des Sel; 2007 Sep; 20(9):417-23. PubMed ID: 17681974
[TBL] [Abstract][Full Text] [Related]
2. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
3. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
4. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
Schiewe AJ; Haworth IS
J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
[TBL] [Abstract][Full Text] [Related]
5. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
Tung CW; Ho SY
Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
[TBL] [Abstract][Full Text] [Related]
6. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
[TBL] [Abstract][Full Text] [Related]
7. Predicting class I major histocompatibility complex (MHC) binders using multivariate statistics: comparison of discriminant analysis and multiple linear regression.
Doytchinova IA; Flower DR
J Chem Inf Model; 2007; 47(1):234-8. PubMed ID: 17238269
[TBL] [Abstract][Full Text] [Related]
8. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
Tian F; Yang L; Lv F; Yang Q; Zhou P
Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
[TBL] [Abstract][Full Text] [Related]
9. A set of new amino acid descriptors applied in prediction of MHC class I binding peptides.
Liang G; Yang L; Chen Z; Mei H; Shu M; Li Z
Eur J Med Chem; 2009 Mar; 44(3):1144-54. PubMed ID: 18662841
[TBL] [Abstract][Full Text] [Related]
10. Peptide length-based prediction of peptide-MHC class II binding.
Chang ST; Ghosh D; Kirschner DE; Linderman JJ
Bioinformatics; 2006 Nov; 22(22):2761-7. PubMed ID: 17000752
[TBL] [Abstract][Full Text] [Related]
11. Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach.
Christensen JK; Lamberth K; Nielsen M; Lundegaard C; Worning P; Lauemøller SL; Buus S; Brunak S; Lund O
Neural Comput; 2003 Dec; 15(12):2931-42. PubMed ID: 14629874
[TBL] [Abstract][Full Text] [Related]
12. Structural prediction of peptides bound to MHC class I.
Fagerberg T; Cerottini JC; Michielin O
J Mol Biol; 2006 Feb; 356(2):521-46. PubMed ID: 16368108
[TBL] [Abstract][Full Text] [Related]
13. Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome.
Vider-Shalit T; Raffaeli S; Louzoun Y
Mol Immunol; 2007 Feb; 44(6):1253-61. PubMed ID: 16930710
[TBL] [Abstract][Full Text] [Related]
14. Class II HLA-peptide binding prediction using structural principles.
Mohanapriya A; Lulu S; Kayathri R; Kangueane P
Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
[TBL] [Abstract][Full Text] [Related]
15. Consensus motifs and peptide ligands of MHC class I molecules.
Falk K; Rötzschke O
Semin Immunol; 1993 Apr; 5(2):81-94. PubMed ID: 7684938
[TBL] [Abstract][Full Text] [Related]
16. QSAR method for prediction of protein-peptide binding affinity: application to MHC class I molecule HLA-A*0201.
Zhao C; Zhang H; Luan F; Zhang R; Liu M; Hu Z; Fan B
J Mol Graph Model; 2007 Jul; 26(1):246-54. PubMed ID: 17275373
[TBL] [Abstract][Full Text] [Related]
17. Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical properties.
Cui J; Han LY; Lin HH; Zhang HL; Tang ZQ; Zheng CJ; Cao ZW; Chen YZ
Mol Immunol; 2007 Feb; 44(5):866-77. PubMed ID: 16806474
[TBL] [Abstract][Full Text] [Related]
18. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
Duquesnoy RJ; Marrari M
Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
[TBL] [Abstract][Full Text] [Related]
19. Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201.
Buchli R; Vangundy RS; Giberson CF; Hildebrand WH
J Immunol Methods; 2006 Jul; 314(1-2):38-53. PubMed ID: 16844138
[TBL] [Abstract][Full Text] [Related]
20. Computational vaccinology: quantitative approaches.
Flower DR; McSparron H; Blythe MJ; Zygouri C; Taylor D; Guan P; Wan S; Coveney PV; Walshe V; Borrow P; Doytchinova IA
Novartis Found Symp; 2003; 254():102-20; discussion 120-5, 216-22, 250-2. PubMed ID: 14712934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
